1. In the search of noninvasive methods delineating left bundle branch block amendable with conduction system pacingTadej Žlahtič, Vito Starc, David Žižek, Martin Rauber, Bor Antolič, Miha Mrak, Maja Ivanovski, Anja Zupan Mežnar, 2026, drugi znanstveni članki Povzetek: Conduction system pacing (CSP) is an emerging new method of cardiac resynchronization therapy (CRT), however, one third of patients with left bundle branch block (LBBB) have distal conduction disease, which is not amenable to correction with CSP. There is an emerging need for tailored analysis of ventricular depolarization patterns for patient selection for CRT pacing modality. We retrospectively analyzed 12 lead hrECGs, equivalent dipole (ED) trajectories and standard transthoracic echocardiograms of 18 heart failure patients fulfilling Strauss criteria for LBBB and indication for CRT randomized to the CSP arm of the ongoing CSP-Sync study (NCT05155865). Based on achievement of left bundle branch capture with shortening of left ventricular activation time, 12 patients had proximal LBBB (pLBBB group), and 6 had intact proximal LBBB conduction (dLBBB group) with similar average baseline QRS durations between the groups (179±14 ms in the pLBBB and 165±20 ms in the dLBBB group, p = 0.1). All patients fulfilled the Strauss criteria with no significant difference in the additional criterion (R wave > 0.1 mV in V1; p = 0.7). In the pLBBB group ED trajectory had an initial leftward direction (six vs. zero patients, p = 0.03) with a uniform (12 vs. one patient, p < 0.001) and slower (0.57 ± 0.12 m/s in the pLBBB vs. 0.75 ± 0.15 m/s in the dLBBB group, p = 0.01) velocity. After 6 months the pLBBB group achieved greater relative QRS duration shortening (26% ± 8% vs. 14% ± 9%; p < 0.02) and relative reductions in end left ventricle systolic volumes (41.3% ± 17.6% vs. 15.8% ± 6.1%; p = 0.004) with better improvement in ejection fraction (17.1% ± 11.0% vs. 5.5% ± 1.0%; p = 0.02). The ED trajectories from 12-lead hrECGs could better differentiate patients with proximal or distal LBBB than standard 12-lead ECG alone. Ključne besede: 12-lead electrocardiography, body surface potential mapping, cardiac resynchronization therapy, conduction system pacing, left bundle branch block Objavljeno v DiRROS: 06.07.2026; Ogledov: 168; Prenosov: 108
Povezava na datoteko |
2. AV-optimized conduction system pacing for treatment of AV dromotropathy : a randomized, cross-over studyAnja Zupan Mežnar, Miha Mrak, Wilfried Mullens, Jernej Štublar, Maja Ivanovski, David Žižek, 2024, izvirni znanstveni članek Povzetek: Background: Severe first-degree atrioventricular (AV) block may produce symptoms similar to heart failure due to AV dyssynchrony, a syndrome termed AV dromotropathy. According to guidelines, it should be considered for permanent pacemaker implantation, yet evidence supporting this treatment is scarce. Objectives: This study aimed to determine the impact of AV-optimized conduction system pacing (CSP) in patients with symptomatic severe first-degree AV block and echocardiographic signs of AV dyssynchrony. Methods: Patients with symptomatic first-degree AV block (PR > 250 ms), preserved left ventricular ejection fraction, narrow QRS, and AV dyssynchrony were included in the study. In a single-blind cross-over design, patients were randomized to AV sequential CSP or backup VVI pacing with a base rate of 40 bpm. We compared exercise capacity, echocardiographic parameters, and symptom occurrence at the end of 3 months of each period. Results: Fourteen patients completed the study. During the AV-optimized CSP compared to the backup pacing period, patients achieved a higher workload on exercise test (147.2 ± 50.9 vs. 140.7 ± 55.8 W; p = .032), with a trend towards higher peak VO2 (23.3 ± 7.1 vs. 22.8 ± 7.1 mL/min/kg; p = .224), and higher left ventricular stroke volume (LVSV 74.5 ± 13.8 vs. 66.4 ± 12.5 mL; p < .001). Symptomatic improvement was recorded, with fewer patients reporting general tiredness and 71% of patients preferring the AV-optimized CSP (p = .008). Conclusions: AV-optimized CSP could improve symptoms, exercise capacity and LVSV in patients with severe first-degree AV block Ključne besede: AV coupling, AV dromotropathy, AV dyssynchrony, conduction system pacing, first‐degree AV block Objavljeno v DiRROS: 11.06.2026; Ogledov: 216; Prenosov: 232
Celotno besedilo (1,95 MB) Gradivo ima več datotek! Več... |
3. Left bundle branch area pacing vs right ventricular pacing for atrioventricular block : the MELOS RELOADED studyMarek Jastrzębski, Grzegorz Kiełbasa, Oscar Cano, Karol Curila, Francesco Zanon, David Žižek, 2026, izvirni znanstveni članek Povzetek: Background and Aims: Left bundle branch area pacing (LBBAP) promotes physiological synchronous activation of the left ventricle and may be particularly beneficial in patients with atrioventricular block (AVB), but its mortality benefit remains unclear. This study aims to compare long-term survival in AVB patients receiving either LBBAP or right ventricular pacing (RVP) and to analyse predictors of mortality during LBBAP. Methods: MELOS RELOADED, a multicentre European collaboration, was a registry-based study of pacemaker patients with AVB, left ventricular ejection fraction (LVEF) >40% and ventricular pacing >20%. The primary outcome was all-cause mortality based on national registries. A 1:1 propensity score matching was performed between the RVP and LBBAP groups. Kaplan–Meier curves and multivariable Cox proportional hazards models were used to estimate survival. Results: In total, 3382 patients receiving LBBAP or RVP were matched. At 4-year follow-up, the Kaplan–Meier curve showed an absolute difference in survival of 11.8% in favour of LBBAP (P < .001). LBBAP was a robust predictor of reduced mortality with a hazard ratio (HR) of 0.53 (95% confidence interval 0.42–0.65, P < .001). Within the LBBAP group, the following independent predictors of increased mortality were identified: lack of confirmed left bundle branch capture (HR 1.85, P < .001), lower percentage of ventricular pacing (HR 1.12), and age. Conclusions: This is the first large study demonstrating the long-term survival benefit of LBBAP. This strengthens the use of LBBAP in AVB patients with preserved/mildly reduced LVEF while awaiting the results of randomized trials. Confirmation of left bundle branch capture seems advisable to achieve optimal results with LBBAP. Ključne besede: conduction system pacing, left bundle branch area pacing, atrioventricular block, mortality, heart failure Objavljeno v DiRROS: 10.04.2026; Ogledov: 1120; Prenosov: 312
Celotno besedilo (1,22 MB) Gradivo ima več datotek! Več... |
4. Predictors of stroke volume improvement with AV-optimized conduction system pacing in patients with AV dromotropathyAnja Zupan Mežnar, Tadej Žlahtič, Miha Mrak, Maja Ivanovski, David Žižek, 2026, drugi znanstveni članki Povzetek: Aims: Patients with first-degree atrioventricular (AV) block and mechanical AV dyssynchrony can present with heart failure (HF)- like symptoms. AV-optimized conduction system pacing (CSP) can improve haemodynamics and symptoms, but selection criteria remain uncertain. We aimed to identify electrocardiographic and echocardiographic predictors of an acute haemodynamic response to AV-optimized CSP in symptomatic first-degree AV block. Methods and Results: Nineteen patients (mean age 60.5 ± 21.1 years; 37% female) with symptomatic first-degree AV block underwent baseline electrocardiography and echocardiography followed by AV-optimized conduction system pacing and repeat echocardiographic assessment. Electrocardiographic parameters (PR interval, P wave duration/PR interval ratio) and echocardiographic indices (E/A wave confluence, A-Q interval, and DFT/RR ratio) were tested for association with change in left ventricular stroke volume (LVSV). The mean PR interval was 395 ± 61 ms, the mean A-Q interval 155 ± 65 ms, and the mean DFT/RR ratio 0.34 ± 0.1. E/A wave confluence was present in 15 patients (79%). AV-optimized pacing increased LVSV by 7.8 ± 3.9 ml, corresponding to an 11.8 ± 5.7% relative increase (P < .01). Echocardiographic parameters were associated with LVSV response, including A-Q interval (r = 0.63, P = .004), DFT/RR ratio (r = −0.59, P = .008), and E/A wave confluence (r = 0.57, P = .01). Electrocardiographic parameters were not associated with LVSV change. Conclusions: Echocardiographically assessed mechanical AV dyssynchrony, rather than electrocardiographic parameters, is associated with an acute haemodynamic response to pacing. Echocardiographic evaluation may help identify patients with prolonged PR interval who could benefit from AV-optimized CSP. Ključne besede: atrioventricular dyssynchrony, atrioventricular conduction block, conduction system pacing, atrioventricular optimization Objavljeno v DiRROS: 08.04.2026; Ogledov: 325; Prenosov: 300
Celotno besedilo (306,59 KB) Gradivo ima več datotek! Več... |
5. Conduction system pacing vs. biventricular pacing for cardiac resynchronization : the CSP-SYNC randomized single centre studyDavid Žižek, Tadej Žlahtič, Miha Mrak, Maja Ivanovski, Jernej Štublar, Dinko Zavrl, Jakob Peterlin, Marta Cvijić, Anja Zupan Mežnar, 2025, izvirni znanstveni članek Povzetek: Aims: There are limited prospective randomized studies comparing left bundle branch area pacing (LBBAP) and biventricular (BiV) pacing for cardiac resynchronization therapy (CRT). The study tested whether LBBAP is non-inferior to BiV pacing in patients with Class I indication for CRT. Methods and results: The CSP-SYNC study is an investigator-initiated, randomized, single-centre study. Sixty-two patients were randomized 1:1 to LBBAP or BiV. The primary study endpoint was the change in left ventricular ejection fraction (LVEF) at 6 months. Secondary endpoints included changes in echo and clinical parameters after 6 months and 12 months. Thirty-one patients were randomized to each arm. Most patients were males (71%), and 32% had ischaemic cardiomyopathy. At 6 months, similar improvement of LVEF was observed in the LBBAP group compared to the BiV group [14.0% (95% confidence interval (CI): 11.2–16.8) in LBBAP vs. 8.5% (95% CI: 5.6–11.2) in BiV] with a mean intergroup difference of 5.6% (95% CI: 1.6–9.5; P < 0.001 for non-inferiority). Both groups showed comparable decrease in LVESV [−64 mL (95% CI: −78 to −50) vs. −40 mL (95% CI: −54 to −25) respectively, mean difference −24 mL (CI 95%: −44 to −4); P < 0.001 for non-inferiority] and changes in 6-min walk test (P < 0.001 for non-inferiority) and NYHA class (P = 0.011 for non-inferiority). Temporal trends of LV remodelling and heart failure hospitalization rates were also comparable. Conclusion: In patients with a Class I indication for CRT, LBBAP was non-inferior to BiV pacing in improving LVEF and provided similar structural and electrical remodelling. Ključne besede: cardiac resynchronization therapy, biventricular pacing, left bundle branch area pacing, left bundle branch block, conduction system pacing Objavljeno v DiRROS: 05.01.2026; Ogledov: 958; Prenosov: 512
Celotno besedilo (525,53 KB) Gradivo ima več datotek! Več... |
6. The CONDUCT-AF trial : rationale and design of a prospective, randomized, multicentre study comparing conduction system and biventricular pacing in patients undergoing atrioventricular node ablation for heart failure with atrial fibrillationMaja Ivanovski, Miha Mrak, Anja Zupan Mežnar, Matevž Jan, Catalin Pestrea, Sandro Brusich, David Žižek, 2025, izvirni znanstveni članek Povzetek: There is a lack of data from randomized clinical trials comparing treatment outcomes between conduction system pacing (CSP) modalities and biventricular pacing (BVP) in symptomatic patients with refractory atrial fibrillation (AF) scheduled for atrioventricular node ablation (AVNA). The CONDUCT-AF investigates whether CSP is non-inferior to BVP in improving left ventricular ejection fraction (LVEF) and clinical outcomes in heart failure (HF) patients with symptomatic AF undergoing AVNA. This study is an investigator-initiated, prospective, randomized, multicentre clinical trial conducted across 10 European centres, enrolling 82 patients with symptomatic AF, HF with reduced LVEF, and narrow QRS. Participants will be randomized 1:1 to CSP or BVP with subsequent AVNA and followed for at least 24 months. The primary endpoint is the change in LVEF after 6 months. Secondary endpoints will include time to the first occurrence of worsening HF or cardiovascular death and its individual components, total number of HF hospitalizations, change in quality of life, N-terminal pro-B-type natriuretic peptide, 6-min walk test distance, and safety outcomes. The CONDUCT-AF trial will provide critical insights into the optimal pacing modality for patients with HF and refractory AF undergoing AVNA. Recruitment is expected to conclude in 2025, with the first study results anticipated in 2026. Ključne besede: atrioventricular node ablation, atrial fibrillation, conduction system pacing, biventricular pacing, heart failure Objavljeno v DiRROS: 05.12.2025; Ogledov: 1312; Prenosov: 464
Celotno besedilo (640,72 KB) Gradivo ima več datotek! Več... |